Liberia Medicines & Health Products Regulatory Authority

Liberia Medicines & Health Products Regulatory Authority LMHRA is charged with the responsibilty to ensure that all medicines and health products consume in Liberia are safe, effective and of good quality

FOR IMMEDIATE RELEASELMHRA Showcases Regulatory Progress At Global Drug Regulatory Conclave 2026 In IndiaMonrovia, Augus...
04/08/2026

FOR IMMEDIATE RELEASE

LMHRA Showcases Regulatory Progress At Global Drug Regulatory Conclave 2026 In India

Monrovia, August 2026– The Liberia Medicines & Health Products Regulatory Authority (LMHRA) represented Liberia at the Global Drug Regulatory Conclave (GDRC) 2026, held on July 30–31, 2026, at Bharat Mandapam in New Delhi, India.

The high-level international forum, jointly organized by India's Central Drugs Standard Control Organization (CDSCO) and the Pharmaceutical Export Promotion Council of India (PHARMEXCIL), brought together medicines regulatory authorities from more than 50 countries, alongside global pharmaceutical and healthcare stakeholders to advance regulatory cooperation and innovation.

Representing LMHRA, Dr. Matu K. Fayiah-Nyanti, Manager of the Post-Market Surveillance Unit, delivered a presentation titled: "Quality Without Borders: Shared Responsibility," highlighting Liberia's progress in strengthening medicines regulation through improved product registration, post-market surveillance, pharmacovigilance, laboratory oversight, quality assurance, and regulatory enforcement.

She emphasized LMHRA's collaboration with the Ministry of Health, law enforcement agencies, customs authorities, regional institutions, and international partners to combat counterfeit and substandard medical products while ensuring access to safe, effective, and quality-assured medicines. Dr. Fayiah-Nyanti also called for enhanced international regulatory cooperation and increased access to Indian Pharmacopoeia (IP) reference standards to strengthen Liberia's medicines quality testing capacity.

Following her return, Dr. Fayiah-Nyanti formally presented her GDRC Training Certificate to LMHRA Managing Director Hon. Dr. Luke L. Bawo and Deputy Managing Director Madam Patricia Qaye-Freeman. She expressed appreciation to the Authority for the opportunity and pledged to apply the knowledge acquired to further strengthen regulatory services and public health protection in Liberia.

The LMHRA leadership commended Dr. Fayiah-Nyanti for representing both the Authority and Liberia with distinction and encouraged her to share the knowledge and experience gained with colleagues. "This reflects LMHRA's continued commitment to institutional capacity building, professional development, and strengthening Liberia's medicines regulatory system," the leadership noted.

The Authority remains committed to ensuring that all medicines and health products available in Liberia meet the highest standards of quality, safety, and efficacy through innovation, collaboration, and international partnerships.
# # #

Media Contact
Risk Communications & Public Relations Unit
Liberia Medicines & Health Products Regulatory Authority
(LMHRA)

LMHRA Wraps Up Training To Boost Pharmaceutical and Healthcare Waste Management SkillsCAREYSBURG, Liberia, July 18, 2026...
21/07/2026

LMHRA Wraps Up Training To Boost Pharmaceutical and Healthcare Waste Management Skills

CAREYSBURG, Liberia, July 18, 2026—The Liberia Medicines and Health Products Regulatory Authority (LMHRA) has just wrapped up an intensive three-day training session focused on enhancing the skills and operational know-how of those tasked with managing pharmaceutical and healthcare waste.

Taking place from July 15–17, 2026, at the Authority's Waste Management Facility in Kings Farm, Careysburg, the training brought together 20 dedicated staff members from the Quality Control Laboratory (QCL) and the Pharmaceutical Waste Management Site. This initiative, organized by the Human Resource Department in partnership with the Office of the Training Manager, is part of LMHRA's ongoing dedication to workforce development and strengthening institutional capacity.

During the opening remarks, LMHRA Managing Director, Dr. Luke L. Bawo, highlighted the vital role that effective pharmaceutical and healthcare waste management plays in protecting public health and the environment. "Improper disposal of pharmaceutical and healthcare waste poses significant risks to public health and the environment, including the contamination of water sources, soil degradation, and adverse effects on local communities," Dr. Bawo stated.

He added, "This training aims to equip our personnel with the essential knowledge and practical skills needed to manage waste safely and in line with both national and international standards." Dr. Bawo encouraged the participants to take the insights and best practices gained from the training and apply them to enhance the Authority's waste management efforts, ultimately supporting Liberia's broader public health goals.

In addition, Waste Management Site Manager Francis S. Mulbah reiterated LMHRA's commitment to ensuring that pharmaceutical and healthcare waste management systems are safe, efficient, and environmentally responsible. He emphasized that ongoing investment in developing staff capabilities is crucial for meeting regulatory standards while also enhancing operational efficiency and environmental responsibility.

During the three-day program, participants engaged in both classroom learning and hands-on demonstrations that spanned a wide array of technical and regulatory subjects. These included: classifying and segregating pharmaceutical and healthcare waste; safe procedures for handling and disposing of waste; practices for occupational health and safety; measures for infection prevention and control; the correct use of Personal Protective Equipment (PPE); protocols for waste reception, storage, and transportation; healthcare waste incineration technology; operating equipment and preventive maintenance; as well as documentation, monitoring, and reporting systems; and national policies, regulations, and international best practices related to healthcare waste management.

The participants hailed from key operational units within the Authority, such as site managers, supervisors, health and safety officers, incinerator operators, maintenance officers, laboratory technicians, waste reception officers, and other technical staff involved in waste management. This multidisciplinary training was led by experts from various departments within LMHRA, showcasing the Authority's cohesive approach to institutional learning, regulatory adherence, and operational excellence.

By enhancing the skills of frontline staff, this initiative underscores LMHRA's dedication to managing pharmaceutical and healthcare waste in a safe, responsible, and sustainable manner, all while reducing environmental risks and safeguarding communities. This training is part of LMHRA's larger strategy to cultivate a highly skilled workforce that can effectively regulate medicines and health products, as well as promote environmental sustainability throughout Liberia's healthcare system.

Established by an Act of the National Legislature in 2010, the Liberia Medicines and Health Products Regulatory Authority (LMHRA) is mandated to ensure the safety, quality, and efficacy of medicines and health products, and to properly regulate them in Liberia, thereby protecting and promoting public health.

09/07/2026

LMHRA Managing Director, Dr. Luke L. Bawo speaks at the Ministry of Information regular press briefing on the gains made regarding the implementation of the LMHRA Strategic plan (2026-2030), the Modernization of the Quality Control Laboratory and the Newly Constructed Pharmaceutical Waste Management Site.

09/07/2026

LMHRA Head of Management, Dr. Luke L. Bawo speaks at the Ministry of Information regular press briefing on the gains made regarding the implementation of the LMHRA Strategic plan (2026-2030), the Modernization of the Quality Control Laboratory and the Newly Constructed Pharmaceutical Waste Management Site.

07/07/2026

LMHRA Head of Post Market Surveillance, Dr. Matu Nyanti appears as a guest on the "Road Way To Health" a regular health talk show organized by the ministry of health; every Tuesday.

MEDIA ALERT! MEDIA ALERT!! MEDIA ALERT!!! One unscrupulous individual, with Orange number 0772305422 registered under th...
06/07/2026

MEDIA ALERT! MEDIA ALERT!! MEDIA ALERT!!!

One unscrupulous individual, with Orange number 0772305422 registered under the name H. NIAREE, is impersonating as the Managing Director of the Liberia Medicines and Health Products Regulatory Authority (LMHRA), Hon. Luke L. Bawo, and criminally soliciting money from Pharmaceutical Importers. Let it be known that the Managing Director will neither solicit nor accept any such money, whether on account of the entity or otherwise. The Pharmaceutical Importers and the general public are advised to be on the alert and report to the LMHRA or any security agency any individual soliciting money from them using the name of the Managing Director or anyone else in the employ of the entity.

MEDIA ALERT
06/07/2026

MEDIA ALERT

Address

Mamba Point
Monrovia

Opening Hours

Monday 09:00 - 17:00
Tuesday 09:00 - 17:00
Wednesday 09:00 - 17:00
Thursday 09:00 - 17:00
Friday 09:00 - 17:00

Telephone

+231777140555

Website

Alerts

Be the first to know and let us send you an email when Liberia Medicines & Health Products Regulatory Authority posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Liberia Medicines & Health Products Regulatory Authority:

Shortcuts

Share

Category